34
Participants
Start Date
August 31, 2015
Primary Completion Date
June 30, 2018
Study Completion Date
June 30, 2018
Feraheme
Feraheme is an USPIO agent, which will be applied as a contrast agent to visualize vascular inflammation in unilateral migraine without aura.
Cilostazol
Cilostazol will be applied to provoke migraine attacks in migraineurs
USPIO-MRI
USPIO-MRI scans will be performed in order to assess possible vascular inflammation associated with migraine attacks.
BBI-MRI
Black blood MRI scans will be performed in order to asses changes in vessel wall thickness due to possible vascular inflammation associated with migraine attacks.
Rigshospitalet Glostrup, Glostrup Municipality
Danish Headache Center
OTHER